Sipuleucel-T Manufacturing Demonstration Study

Registry ID

EUCTR2011-001192-39

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Dendreon Corporation

Start date

2012-01-26

Completion date

2014-06-10

Last update

2026-08-16

Conditions

• metastatic castrate resistant prostate cancer

Summary

To demonstrate that sipuleucel-T can be successfully manufactured for subjects with mCRPC at a European manufacturing facility.

Locations

• , , Netherlands
• , , Austria
• , , UK

View on source registry